Carmustine and Physostigmine share 8 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.348 means 35% of the combined target set is bound by both compounds. The IDF-weighted score of 0.285 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Carmustine and Physostigmine have in common?
Carmustine and Physostigmine share 8 molecular targets with a Jaccard similarity of 35%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Carmustine and Physostigmine be combined?
Carmustine and Physostigmine share 8 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Carmustine or Physostigmine?
In the BiohacksAI corpus: Carmustine has 297 PubMed-indexed studies, Physostigmine has 300 studies.